99 related articles for article (PubMed ID: 2330900)
1. Decreased coronary vasodilatory capacity in hypertrophic cardiomyopathy determined by split-dose thallium-dipyridamole myocardial scintigraphy.
Koga Y; Yamaguchi R; Ogata M; Kihara K; Toshima H
Am J Cardiol; 1990 May; 65(16):1134-9. PubMed ID: 2330900
[TBL] [Abstract][Full Text] [Related]
2. [Dipyridamole-echocardiography and thallium exercise myocardial scintigraphy in the diagnosis of obstructive coronary or microvascular disease in hypertensive patients with left ventricular hypertrophy and angina].
Astarita C; Nicolai E; Liguori E; Gambardella S; Rumolo S; Maresca FS
G Ital Cardiol; 1998 Sep; 28(9):996-1004. PubMed ID: 9788038
[TBL] [Abstract][Full Text] [Related]
3. Therapeutic effect of oral dipyridamole on myocardial perfusion and cardiac performance in patients with hypertrophic cardiomyopathy.
Koga Y; Kihara K; Yamaguchi R; Wada T; Toshima H
Am Heart J; 1992 Feb; 123(2):433-8. PubMed ID: 1736582
[TBL] [Abstract][Full Text] [Related]
4. [Decreased coronary reserve in patients with hypertrophic cardiomyopathy--a study using split dose thallium-201 dipyridamole myocardial imaging].
Yamaguchi R
Kokyu To Junkan; 1987 Jan; 35(1):97-103. PubMed ID: 3563138
[No Abstract] [Full Text] [Related]
5. Dipyridamole-induced ST segment depression during thallium-201 imaging in patients with coronary artery disease: angiographic and hemodynamic determinants.
Chambers CE; Brown KA
J Am Coll Cardiol; 1988 Jul; 12(1):37-41. PubMed ID: 3379218
[TBL] [Abstract][Full Text] [Related]
6. [Hypertrophic non-obstructive cardiomyopathy assessed by dipyridamole thallium single photon emission computed tomography: comparisons with hypertrophic cardiomyopathy with a dilated heart].
Mori T; Suda K; Ohnishi M; Kanoh Y; Shiotani H; Yokota Y; Fujitani K; Fukuzaki H; Maeda K
J Cardiol; 1987 Mar; 17(1):35-46. PubMed ID: 3501444
[TBL] [Abstract][Full Text] [Related]
7. [Dipyridamole thallium-201 myocardial scintigraphy in coronary diagnosis; a comparison of methods with thallium-201 myocardial scintigraphy after ergometer stress].
Neuzner J; Kornecki P; Kremer P; Grebe S; Schlepper M
Z Kardiol; 1987 Dec; 76(12):737-43. PubMed ID: 3439248
[TBL] [Abstract][Full Text] [Related]
8. Myocardial metabolic, hemodynamic, and electrocardiographic significance of reversible thallium-201 abnormalities in hypertrophic cardiomyopathy.
Cannon RO; Dilsizian V; O'Gara PT; Udelson JE; Schenke WH; Quyyumi A; Fananapazir L; Bonow RO
Circulation; 1991 May; 83(5):1660-7. PubMed ID: 2022023
[TBL] [Abstract][Full Text] [Related]
9. [Use of myocardial scintigraphy with 201Tl for differential diagnosis of ischemic heart disease and hypertrophic cardiomyopathy in women].
Spizhovyĭ VN; Kramer AA; Gasilin VS; Liakishev AA; Samoĭlenko LE
Kardiologiia; 1983 Aug; 23(8):51-5. PubMed ID: 6684709
[TBL] [Abstract][Full Text] [Related]
10. [Assessment of coronary stenosis by myocardial scintigraphy with thallium-201 after dipyridamol infusion].
Pirelli S; Inglese E; Suppa M; Corrada E; Piccalò G; Campolo L; Carù B
G Ital Cardiol; 1985 May; 15(5):520-5. PubMed ID: 4054490
[TBL] [Abstract][Full Text] [Related]
11. Quantitative comparison of thallium-201 scintigraphy after exercise and dipyridamole in coronary artery disease.
Varma SK; Watson DD; Beller GA
Am J Cardiol; 1989 Oct; 64(14):871-7. PubMed ID: 2801554
[TBL] [Abstract][Full Text] [Related]
12. Coronary vasodilation is impaired in both hypertrophied and nonhypertrophied myocardium of patients with hypertrophic cardiomyopathy: a study with nitrogen-13 ammonia and positron emission tomography.
Camici P; Chiriatti G; Lorenzoni R; Bellina RC; Gistri R; Italiani G; Parodi O; Salvadori PA; Nista N; Papi L
J Am Coll Cardiol; 1991 Mar; 17(4):879-86. PubMed ID: 1999624
[TBL] [Abstract][Full Text] [Related]
13. Significance of positive or negative thallium-201 scintigraphy in hypertrophic cardiomyopathy.
von Dohlen TW; Prisant LM; Frank MJ
Am J Cardiol; 1989 Sep; 64(8):498-503. PubMed ID: 2773793
[TBL] [Abstract][Full Text] [Related]
14. Coronary vasodilator reserve in primary and secondary left ventricular hypertrophy. A study with positron emission tomography.
Choudhury L; Rosen SD; Patel D; Nihoyannopoulos P; Camici PG
Eur Heart J; 1997 Jan; 18(1):108-16. PubMed ID: 9049522
[TBL] [Abstract][Full Text] [Related]
15. Impaired coronary vasodilatory capacity after dipyridamole administration in hypertrophic cardiomyopathy.
Shimamatsu M; Toshima H
Jpn Heart J; 1987 May; 28(3):387-401. PubMed ID: 3626022
[TBL] [Abstract][Full Text] [Related]
16. Dipyridamole stress thallium-201 perfusion abnormalities in patients with hypertrophic cardiomyopathy. Relationship to clinical presentation and outcome.
Yamada M; Elliott PM; Kaski JC; Prasad K; Gane JN; Lowe CM; Doi Y; McKenna WJ
Eur Heart J; 1998 Mar; 19(3):500-7. PubMed ID: 9568455
[TBL] [Abstract][Full Text] [Related]
17. [Thallium-dipyridamole in acute myocardial infarction treated by thrombolysis: diagnostic and prognostic value].
D'Urbano M; Cafiero F; Cammelli F; Spreafico GL; Romano S
G Ital Cardiol; 1994 Jan; 24(1):11-20. PubMed ID: 8200491
[TBL] [Abstract][Full Text] [Related]
18. Myocardial thallium defects in apical hypertrophic cardiomyopathy are associated with a benign prognosis. Thallium defects in apical hypertrophy.
Lee KH; Jang HJ; Lee SC; Kim YH; Lee EJ; Seo JD; Kim BT
Int J Cardiovasc Imaging; 2003 Oct; 19(5):381-8. PubMed ID: 14609187
[TBL] [Abstract][Full Text] [Related]
19. Prediction of in-hospital cardiac events using dipyridamole-thallium scintigraphy performed very early after acute myocardial infarction.
Bosch X; Magriñá J; March R; Sanz G; García A; Betriu A; Navarro-López F
Clin Cardiol; 1996 Mar; 19(3):189-96. PubMed ID: 8674255
[TBL] [Abstract][Full Text] [Related]
20. Radionuclide imaging after coronary vasodilation: myocardial scintigraphy with thallium-201 and radionuclide angiography after administration of dipyridamole.
Sochor H; Pachinger O; Ogris E; Probst P; Kaindl F
Eur Heart J; 1984 Jun; 5(6):500-9. PubMed ID: 6745292
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
